The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
Open accessAbstract
BACKGROUND: Physicians avoid the use of beta-blockers in patients with chronic obstructive pulmonary disease (COPD) and concurrent cardiovascular disease because of concerns about adverse pulmonary effects. We assessed the long-term effect of beta-blocker use on survival and exacerbations in patients with COPD. METHODS: An observational cohort study using data from the electronic medical records of 23 general practices in the Netherlands. The data included standardized information about daily patient contacts, diagnoses, and drug prescriptions. RESULTS: In total, the study included 2230 patients 45 years and older with an incident or prevalent diagnosis of COPD between 1996 and 2006. The mean (SD) age of the patients with COPD was 64.8 (11.2) years at the start of the study, and 53% of the patients were male. During a mean (SD) follow-up of 7.2 (2.8) years, 686 patients (30.8%) died and 1055 (47.3%) had at least 1 exacerbation of COPD. The crude and adjusted hazard ratios with Cox regression analysis of beta-blocker use for mortality were 0.70 (95% confidence interval [CI], 0.59-0.84) and 0.68 (95% CI, 0.56-0.83), respectively. The crude and adjusted hazard ratios for exacerbation of COPD were 0.73 (95% CI, 0.63-0.83) and 0.71 (95% CI, 0.60-0.83), respectively. The adjusted hazard ratios with the propensity score methods were even lower. Subgroup analyses revealed that patients with COPD but without overt cardiovascular disease had similar results. CONCLUSION: Treatment with beta-blockers may reduce the risk of exacerbations and improve survival in patients with COPD, possibly as a result of dual cardiopulmonary protective properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Rabe, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · Cited by 2,567
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174516 · Cited by 2,104
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062
Gottlieb, S. S., McCarter, R. J., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 982
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C. L., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 911
A critical look at methods for handling missing covariates in epidemiologic regression analyses.
Greenland, S., & Finkle, W. D. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117592 · Cited by 891 · cited 1×
“As the exclusion of patients with a missing value (so-called complete case analysis) may lead to biased results and loss of power, we imputed missing values for smoking status by using a regression method with the addition of a random error term.(24) Imputation was based on the correlation between this missing variabl…”
MethodUnrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease
Rutten, F. H., Cramer, M.-J. M., Grobbee, D. E., Sachs, A. P. E., Kirkels, J. H., Lammers, J.-W. J., & Hoes, A. W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi291 · Cited by 452
Self-citationMancini, G. B. J., Etminan, M., Zhang, B., Levesque, L. E., FitzGerald, J. M., & Brophy, J. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.039 · Cited by 402
Cardioselective beta-blockers for chronic obstructive pulmonary disease
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003566.pub2 · Cited by 381
Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S. (1996) · Circulation · doi:10.1161/01.cir.94.4.690 · Cited by 353
Heart Failure and cHronic Obstructive Pulmonary Disease: An Ignored Combination?
Rutten, F. H., Cramer, M.-J. M., Lammers, J.-W. J., Grobbee, D. E., & Hoes, A. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.010 · Cited by 291
Self-citationStatin use is associated with reduced mortality in COPD
Søyseth, V., Brekke, P. H., Smith, P., & Omland, T. (2007) · European Respiratory Journal · doi:10.1183/09031936.00106406 · Cited by 267
Cardioselective β-Blockers in Patients with Reactive Airway Disease: A Meta-Analysis
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-9-200211050-00035 · Cited by 266
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
Rutten, F. H., Moons, K. G. M., Cramer, M.-J. M., Grobbee, D. E., Zuithoff, N. P. A., Lammers, A.-W. J., & Hoes, A. W. (2005) · BMJ · doi:10.1136/bmj.38664.661181.55 · Cited by 241
Self-citationThe Introduction of Computer-based Patient Records in the Netherlands
van der Lei, J., Duisterhout, J. S., Westerhof, H. P., van der Does, E., Cromme, P. V. M., Boon, W. M., & van Bemmel, J. H. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00011 · Cited by 238
McCullough, P. A., Hollander, J. E., Nowak, R. M., Storrow, A. B., Duc, P., Omland, T., McCord, J., Herrmann, H. C., Steg, P. G., Westheim, A., et al. (2003) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2003.tb01990.x · Cited by 218
Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Dransfield, M. T., Rowe, S. M., Johnson, J. E., Bailey, W. C., & Gerald, L. B. (2008) · Thorax · doi:10.1136/thx.2007.081893 · Cited by 209
van Gestel, Y. R. B. M., Hoeks, S. E., Sin, D. D., Welten, G. M. J. M., Schouten, O., Witteveen, H. J., Şimşek, C., Stam, H. J., Mertens, F. W., Bax, J. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-384oc · Cited by 157
Martens, E. P., Pestman, W. R., de Boer, A., Belitser, S. V., & Klungel, O. H. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn079 · Cited by 133
Egred, M., Shaw, S. M., Mohammad, B., Waitt, P. I., & Rodrigues, E. (2005) · QJM · doi:10.1093/qjmed/hci080 · Cited by 129
Cardioselective beta-blockers for reversible airway disease
Salpeter, S. R., Ormiston, T. M., Salpeter, E. E., & Wood-Baker, R. R. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002992 · Cited by 116
Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies
Groenwold, R. H. H., Hak, E., & Hoes, A. W. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.02.011 · Cited by 65
Mechanisms of adverse effects of -agonists in asthma
Johnston, S. L., & Edwards, M. R. (2009) · Thorax · doi:10.1136/thx.2009.119230 · Cited by 42
Stevenson, W., Yancy, C. W., Mancini, M. E., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Francis, S. A., Ganiats, T. G., Jessup, M. L., et al. (2009) · Cited by 22
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Metadata
- Authors
- Rutten, F. H.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-24
- Volume
- 170
- Issue
- 10
- Pages
- 880
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2164132830
- Cited by
- 307
- References
- 31
- FWCI
- 27.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.